Close Menu

NEW YORK (360Dx) – Roche today announced it received CE mark for the Ventana MMR IHC Panel for aid in diagnosing patients with colorectal cancer.

The panel, which also was launched today, provides clinicians with a group of immunohistochemistry tests for detecting certain proteins associated with mismatch repair, and for differentiating between sporadic colorectal cancer and probable Lynch syndrome. Roche said that about 3 percent of colorectal cancers are associated with Lynch syndrome, which results in a 50 to 80 percent lifetime risk of developing colorectal cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.